These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37312837)

  • 1. Discovery of Novel, Selective Prostaglandin EP4 Receptor Antagonists with Efficacy in Cancer Models.
    Das D; Qiao D; Liu Z; Xie L; Li Y; Wang J; Jia J; Cao Y; Hong J
    ACS Med Chem Lett; 2023 Jun; 14(6):727-736. PubMed ID: 37312837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold Hopping Strategy to Identify Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy.
    Wang W; He J; Yang J; Zhang C; Cheng Z; Zhang Y; Zhang Q; Wang P; Tang S; Wang X; Liu M; Lu W; Zhang HK
    J Med Chem; 2022 Jun; 65(11):7896-7917. PubMed ID: 35640059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosanoids in Cancer: Prostaglandin E
    Ching MM; Reader J; Fulton AM
    Front Pharmacol; 2020; 11():819. PubMed ID: 32547404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
    Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
    Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 2
    Cheng Z; Wang Y; Zhang Y; Zhang C; Wang M; Wang W; He J; Wang Y; Zhang H; Zhang Q; Ding C; Wu D; Yang L; Liu M; Lu W
    J Med Chem; 2023 May; 66(9):6218-6238. PubMed ID: 36880691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
    Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Characterization of 1
    Yang JJ; Yu WW; Hu LL; Liu WJ; Lin XH; Wang W; Zhang Q; Wang PL; Tang SW; Wang X; Liu M; Lu W; Zhang HK
    J Med Chem; 2020 Jan; 63(2):569-590. PubMed ID: 31855426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity.
    Albu DI; Wang Z; Huang KC; Wu J; Twine N; Leacu S; Ingersoll C; Parent L; Lee W; Liu D; Wright-Michaud R; Kumar N; Kuznetsov G; Chen Q; Zheng W; Nomoto K; Woodall-Jappe M; Bao X
    Oncoimmunology; 2017; 6(8):e1338239. PubMed ID: 28920002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing effects of prostaglandin E
    Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
    Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
    Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
    J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE
    Ma X; Holt D; Kundu N; Reader J; Goloubeva O; Take Y; Fulton AM
    Oncoimmunology; 2013 Jan; 2(1):e22647. PubMed ID: 23482441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis.
    He J; Lin X; Meng F; Zhao Y; Wang W; Zhang Y; Chai X; Zhang Y; Yu W; Yang J; Li G; Du X; Zhang H; Liu M; Lu W
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35208999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway.
    Xu S; Zhou W; Ge J; Zhang Z
    Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-inflammatory effects of PGE
    Gill SK; Yao Y; Kay LJ; Bewley MA; Marriott HM; Peachell PT
    Br J Pharmacol; 2016 Nov; 173(21):3099-3109. PubMed ID: 27460634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of Dual EP2/EP4 Antagonists through Scaffold Merging of Selective Inhibitors.
    Corminboeuf O; Diethelm S; Zumbrunn C; Lyothier I; Niggli N; Gnerre C; Jeay S; Lehembre F; Boss C
    ChemMedChem; 2024 Jan; 19(2):e202300606. PubMed ID: 37983645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP4 receptor as a novel promising therapeutic target in colon cancer.
    Karpisheh V; Joshi N; Zekiy AO; Beyzai B; Hojjat-Farsangi M; Namdar A; Edalati M; Jadidi-Niaragh F
    Pathol Res Pract; 2020 Dec; 216(12):153247. PubMed ID: 33190014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.